AJP - Regu Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Regul Integr Comp Physiol 288: R1606-R1611, 2005. First published February 3, 2005; doi:10.1152/ajpregu.00817.2004
0363-6119/05 $8.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
288/6/R1606    most recent
00817.2004v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via ISI Web of Science (4)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Drazen, D. L.
Right arrow Articles by Woods, S. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Drazen, D. L.
Right arrow Articles by Woods, S. C.

APPETITE, OBESITY, DIGESTION, AND METABOLISM

Neuropeptide Y prepares rats for scheduled feeding

Deborah L. Drazen, Matthew D. Wortman, Randy J. Seeley, and Stephen C. Woods

Department of Psychiatry, University of Cincinnati, Cincinnati, Ohio

Submitted 2 December 2004 ; accepted in final form 29 January 2005


    ABSTRACT
 TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
When neuropeptide Y (NPY) is administered centrally, meal-anticipatory responses are elicited. If an increase of endogenous NPY is a signal that heralds an imminent large caloric load, timed daily NPY injections may be expected to condition meal-anticipatory responses that facilitate ingestion. Rats received 4-h access to food beginning in the morning and then timed (1600 h), daily third-ventricular injections of NPY or saline for 7 days. On test day (day 8), animals received the conditioning drug (NPY or saline) or the opposite drug. Food was available immediately after injection on test day, and intake was measured. Rats conditioned with NPY and then given saline ate significantly more than rats conditioned with saline and then given saline; they ate the same amount as rats given NPY. Although they ate more, rats trained with NPY did not have changed plasma glucose, insulin, or ghrelin. These data suggest that NPY plays a role in mediating conditionable food-anticipatory responses that help to cope with the effects of large caloric loads.

conditioning; learning; food intake


SEVERAL LINES OF EVIDENCE suggest that consuming large caloric loads poses a metabolic challenge (36, 39). During and after large meals, glucose, fatty acids, and other nutrients flood into the blood from the gut and consequently perturb the rigorously controlled levels of blood nutrients, and insulin and other hormones must be secreted to reduce and hence tolerate the increments. In an endocrine sense, the postprandial elevation of plasma fuels has been considered a stressor in that plasma catecholamines, adrenocorticotropic hormone, glucocorticoids, and {beta}-endorphin are all elevated at that time (10, 21, 25, 36). Although one could argue that individual meal-induced increases in these stress hormones are not major, when hundreds or thousands of meals are considered on a chronic basis, such increases have been implicated in the development of obesity, hypertension, and atherosclerosis (5, 18, 20, 36).

Consistent with this view of meals, animals engage in specific behaviors that help minimize the acute metabolic impact of food. In particular, animals adapt by learning to make anticipatory responses that minimize a meal's impact, and, if they are unable to reliably anticipate a meal, they eat smaller meals (24). The premeal secretion of insulin is an adaptive response that minimizes prandial increases of blood glucose (3, 35, 36), and it is coincident with a premeal reduction in metabolic rate, a premeal elevation of plasma corticosterone, and a premeal increase in body temperature (11, 14, 23, 25), all of which are initiated well in advance of an anticipated meal. The term "cephalic" describes these anticipatory responses because they are initiated by cues in an individual's environment that reliably predict meals, cues that can be considered as conditioned stimuli in a learning sense. As an example, animals readily learn to use time of day to entrain their pattern of food intake. Hence, when maintained on a stable light-dark schedule, they consume the largest meals at the most predictable times, i.e., light offset and light onset (19, 32). There is nothing inherent about the changing of the lights, per se, that mandates that an animal eat larger meals at those precise times because rats trained ("meal-fed") to anticipate food at any arbitrarily selected time during the light-dark cycle eat their largest meal at that time. The point is that the largest meals are eaten at a time that is highly predictable (33).

Neuropeptide Y (NPY) elicits a robust increase in food intake when administered centrally (7, 22, 30). Endogenous NPY levels in the hypothalamus normally peak before the onset of dark and consumption of the largest meal of the day in free-feeding animals (1), and hypothalamic NPY peaks before the time of feeding in meal-fed animals (41, 42). Hence, it is reasonable to speculate that the elevated NPY levels function to facilitate the consumption of a particularly large caloric load. This could occur either because NPY elicits eating per se or because NPY elicits the gamut of anticipatory cephalic responses that secondarily allow a large amount of food to be ingested without eliciting too major a metabolic perturbation.

Consistent with the latter possibility, the administration of exogenous NPY into the brain does not always elicit eating. Eating can be partitioned into the appetitive phase, which refers to the finding and acquisition of food, and the consummatory phase, which consists of eating per se (chewing, swallowing) (8). In models that dissociate the consummatory and appetitive phases of food intake, such as when liquid food is provided freely to rats through an intraoral catheter, NPY given into the brain does not increase the consummatory act of food intake but does cause the same rats to initiate anticipatory, appetitive responses such as approaching and licking the liquid food (2, 27). These data have two important implications. First, at least when we use the above-mentioned model and rats need not make anticipatory responses to get food, NPY has no effect on food intake. Second, these data suggest that once anticipatory behaviors have been elicited by NPY and food is available, intake is excessive.

In support of the hypothesis that NPY functions to mediate food-anticipatory responses, when NPY is administered centrally, responses are elicited that resemble those made when consuming food is anticipated, including insulin and corticosterone secretion (26), increased corticotropin-releasing hormone (CRH) mRNA and CRH-immunoreactivity in the hypothalamus (15, 34), and increased locomotor activity (29). Collectively, these data lead to the hypothesis that hypothalamic NPY, rather than functioning to increase food intake per se, mediates food-anticipatory responses that help to lessen the metabolic impact of a large caloric load.

If NPY is a signal that heralds the opportunity to consume an imminent large caloric load, we reasoned that receiving third-ventricular (i3vt) injection NPY at the same time each day for several days should prepare animals to ingest a large quantity of food at that time; that is, daily injections of NPY at a specific time should condition meal-anticipatory physiological and behavioral responses that facilitate ingesting a large meal at that specific time, and NPY-conditioned animals should consequently be better prepared for consuming a caloric load at that time than control animals injected at the same time of day with i3vt saline. We assessed this hypothesis in several experiments.


    MATERIALS AND METHODS
 TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
Animals

For all experiments, male Long-Evans rats (300–350 g, Harlan, Indianapolis, IN) were housed in individual tub cages with ad libitum access to pelleted rat chow (Teklad, Harlan, Madison, WI) and water in a temperature-controlled vivarium (22 ± 2°C) on a 12:12-h light-dark schedule, with lights on at 0800 unless otherwise noted. Research was conducted in AAALAC-approved facilities that conformed to National Institutes of Health and U.S. Department of Agriculture regulations; research was approved by the University of Cincinnati Internal Animal Care and Use Committee.

Third-Ventricular Cannulation

All animals were surgically implanted with a 22-gauge cannula (Plastics One, Roanoke, VA) aimed at the third cerebral ventricle as described previously (6). For surgery, rats were anesthetized with intraperitoneal ketamine (86 mg/kg)-xylazine (12.9 mg/kg) and allowed to recover until they reached presurgical body weight (~1 wk). Verification of cannula placement was accomplished by i3vt injection of 10 ng of angiotensin II in 1 µl of 0.9% saline. Animals that did not drink 5 ml of water within 60 min after this treatment were not included in the experiments.

Experimental Procedures

Experiment 1. The goal of experiment 1 was to assess the longevity of NPY's orexigenic action when food is not immediately provided to the animal, i.e., to determine how much time must elapse with no food available before animals no longer overeat once food is presented after they receive i3vt NPY. This was necessary to ensure that the daily injections of NPY in subsequent experiments did not elicit any change in food intake, so that the influence of NPY conditioning could be assessed independent of altering food intake or body weight. It was also necessary to demonstrate that there were no lingering effects of NPY that would have any effect on behavior on subsequent days.

Food was removed from all rat cages at 0900 h. Rats (n = 60) were divided into two i3vt groups: those receiving a single injection of NPY (9.5 µg, American Peptide, Sunnyvale, CA) in 2 µl of saline and those receiving a single injection of saline (2 µl) at 1000 h. This dose was chosen based on previous i3vt NPY dose-response studies (e.g., Ref. 4). The animals were further subdivided into groups that received their food immediately after the injection or 4 or 18 h after the injection. In each of these conditions, food intake was recorded 1 h after food return. Water was available at all times for all groups.

Experiment 2. The goal of experiment 2 was to determine whether cues predictive of NPY are sufficient to allow animals to ingest a large caloric load. To test this, we conditioned animals by administering NPY at the same time each day. On a subsequent test day, the critical group did not receive NPY, allowing us to determine whether the responses to anticipated NPY are sufficient to cause an individual to eat. The nominal conditioned stimulus in this experiment consisted of the time of day and the injection procedure, and the unconditioned stimulus consisted of responses elicited by central NPY that facilitate eating.

Based on the results of experiment 1, a novel cohort of rats (n = 30; maintained as in experiment 1) had access to chow plus water from 1000 to 1400 h daily and had only water available the remainder of the day. Food intake was monitored daily to determine when it reached a plateau, after which the experimental protocol began; i.e., after 12 days, these meal-fed rats were consuming close to their normal (i.e., premeal-feeding) daily caloric load during the 4-h access period. The same meal-feeding schedule was maintained throughout the experiment.

After 12 days of meal feeding, rats were assigned to one of two i3vt groups with equal body weight: one group received NPY (9.5 µg in 2 µl; n = 15) and the other received the vehicle, physiological saline (2 µl; n = 15). The injections were administered for 7 consecutive days (days 1–7), a protocol that we used previously for drug conditioning (38) at precisely 1600 h. Food intake and body weight were recorded each day. On day 8, the test day, animals were fed as on the previous 7 days, from 1000 to 1400. On the test day, animals were further subdivided, with approximately half of each group (NPY or saline on days 1–7) receiving i3vt saline and the other half receiving i3vt NPY (9.5 µg) at 1600 h (throughout the 7 days of training, 4 animals, 2 from each group, became ill and were not included in the rest of the experiment). Thus there were four groups: Sal/Sal (n = 6), Sal/NPY (n = 7), NPY/Sal (n = 7), and NPY/NPY (n = 6). On test day (day 8), immediately after the injection, food was given to each animal (a novel time for food access in all groups), and intake was measured after 1, 2, 4, and 20 h.

Experiment 3. At the conclusion of experiment 2, the same rats were returned to the meal-feeding schedule (food available only from 1000 to 1400) for the next 3 consecutive days (days 10–12; food was removed at 1400 on day 9) to reestablish the conditioned responses (37). Each rat was injected with i3vt NPY or i3vt saline at 1600 on these days, receiving the same drug as on days 1–7. On day 13, rats received their food from 1000 to 1400 (consuming 18.6 ± 0.6 g, similar to what it had been in experiment 2), but no injection was given; instead, all animals were killed at 1600, and trunk blood and brains were harvested. Blood was centrifuged at 4°C for 15 min at 4,000 rpm. Plasma aliquots were aspirated and stored in sealable polypropylene microcentrifuge tubes at –80°C until used for hormone assays. Brains were immediately immersed in 20 ml of RNAlater (Ambion, Austin, TX). Plasma insulin, glucose, and ghrelin were assessed to determine whether NPY conditioning altered hormonal cephalic responses. Hypothalamic NPY gene expression was measured to determine whether endogenous NPY mRNA was influenced by the daily administration of NPY to the brain.

Plasma Glucose, Insulin, and Ghrelin

We measured glucose using a glucose oxidase method. Insulin was determined by a previously described RIA (12). We determined ghrelin values using a commercially available RIA kit (Phoenix Pharmaceuticals, Belmont, CA). The lowest detection limit was 20–30 pg/ml, the intra-assay variation was 5.0%, and the linear range was from 40 to 1,280 pg/ml.

RNA Isolation and cDNA Synthesis

Whole brains were rapidly removed from anesthetized animals and placed in 20 ml of RNAlater (Ambion). After equilibration for 48 h at 4°C, hypothalami were dissected and placed in RNAlater (1.5 ml) and held at –80°C until use. TRI reagent (MRC, Cincinnati, OH) was used to isolate RNA from individual hypothalami according to manufacturer's recommendations. A ratio of 50 mg of tissue per milliliter of TRI reagent was maintained for each sample, and bromochloropropane was used in place of chloroform. The Superscript first-strand synthesis system (Invitrogen, Carlsbad, CA) was used to synthesize cDNA from 5 µg of total RNA.

Semi-Quantitative PCR

Semi-quantitative PCR was performed on a Bio-Rad (Hercules, CA) Icycler using Bio-Rad iQ SYBR green supermix. We performed RT-PCR using Superscript II according to the manufacturer's protocol (Invitrogen). Cycling conditions were initial denaturing step at 95.0°C for 3 min followed by 40 x 2-step cycles at 95.0°C for 10 s and 60.0 °C for 30 s. Primers for rat NPY were designed with MGB Eclipse design software (version 3.0, http://www.epochbio.com). The sequence of the forward primer was CTCTGCGACACTACATCAA, and the reverse primer was GG*GGCATTTTCTGTGCTTT (asterisk denotes that prior nucleotide is chemically modified, see above website for details). PCR efficiency was 101.6%, and the correlation coefficient over five orders of magnitude spanning test concentrations was 0.996. Gel and melt-curve analyses demonstrated no competing products. Samples were run in triplicate and normalized to the constitutively expressed ribosomal protein L32, which has identical reaction characteristics.

Statistical Analyses

For experiment 2, meal-feeding data were analyzed with a t-test; all other data were analyzed with a one-way between-subjects ANOVA. All pairwise comparisons of mean differences were conducted with Tukey's honestly significant difference comparisons. Differences between group means were considered statistically significant if P < 0.05.


    RESULTS
 TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
Experiment 1

As revealed by one-way ANOVA, there was a main effect of the time of food return after injection on food intake (P < 0.05). NPY significantly increased 1-h food intake when food was returned immediately after injection, as well as when food was returned 4 h after injection, compared with saline (P < 0.05 in both cases). The increase in intake elicited by NPY relative to saline was greater in the group receiving food immediately compared with the animals whose food return was delayed by 4 h (P < 0.05 in all cases; Table 1).


View this table:
[in this window]
[in a new window]
 
Table 1. One-hour food intake of rats that received i3vt saline or NPY

 
There was no difference in 1-h food intake after NPY compared with saline when food was returned 18 h after injection (P > 0.05 in all cases; Table 1). NPY significantly increased food intake when food was returned immediately or 4 h after injection (P < 0.05) but not when food was returned 18 h after injection (P > 0.05). Hence, having received NPY 18 h earlier had no discernable effect on food intake. We therefore incorporated an 18-h delay after NPY in experiment 2.

Experiment 2

The relative timing of the 4 h of food availability and the i3vt injections in experiment 2 were determined based on the findings of experiment 1. That is, the food was made available beginning 18 h after the daily injections, a time when the NPY was no longer effective at increasing food intake, so that NPY-conditioned and saline-conditioned animals would have similar behavioral profiles before test day.

All animals significantly increased their food intake over the course of 12 days of 4-h daily meal feeding, as revealed by a t-test that compared food consumed on day 1 (6.47 ± 0.31 g) of meal feeding with that consumed on day 12 (19.47 ± 0.71 g) of meal feeding [t(28) = –15.17, P < 0.05].

Importantly, as revealed by one-way ANOVAs, there was no difference in cumulative food intake between the NPY-conditioned and the saline-conditioned groups over the course of the seven daily i3vt injections [F(1, 28) = 0.136, not significant] (Fig. 1A and see Table 2 for average daily intakes) or in body weight between the NPY-trained and the saline-trained groups just before test day [F(1, 28) = 0.32, not significant] (Fig. 1B and see Table 3 for average daily body weights).



View larger version (10K):
[in this window]
[in a new window]
 
Fig. 1. A: cumulative mean (±SE) food intake in rats that received either 7 consecutive days of third-ventricular injection (i3vt) of saline or neuropeptide Y (NPY; 9.5 µg), with food available only from 1000 to 1400 h. B: mean (±SE) body weight (measured on day 8, before test injection) of rats that had received either 7 consecutive days of i3vt saline or NPY (9.5 µg), with food available only from 1000 to 1400 h.

 

View this table:
[in this window]
[in a new window]
 
Table 2. Food intake of rats that received i3vt saline or NPY on 7 consecutive days

 

View this table:
[in this window]
[in a new window]
 
Table 3. Body weights of rats that received i3vt saline or NPY on 7 consecutive days

 
A one-way ANOVA indicated a main effect of the conditioning group on food intake on the test day, at 1 [F(3, 22) = 7.75], 2 [F(3, 22) = 8.26], and 4 [F(3,22) = 5.59] h (P < 0.1 in all cases). Post hoc analysis revealed that at 1, 2, and 4 h, food intake was significantly greater in the Sal/NPY, NPY/Sal, and NPY/NPY groups than in the Sal/Sal group (P < 0.05 in all cases). Figure 2A depicts the 1-h data, and Table 4 lists the other time points. By 20 h, as revealed by one-way ANOVA, food intake was no longer significantly different among any of the groups [F(3, 22) = 0.31, not significant] (Fig. 2B).



View larger version (31K):
[in this window]
[in a new window]
 
Fig. 2. Mean (±SE) 1-h (A) and 20-h (B) food intake in rats that received either 7 consecutive days of i3vt saline (Sal) or NPY (9.5 µg) and that received either i3vt saline or NPY on the test day. *Significantly different from the Sal/Sal group (P < 0.05).

 

View this table:
[in this window]
[in a new window]
 
Table 4. Cumulative food intake of rats that received i3vt saline or NPY on 7 consecutive days and then received i3vt saline or NPY on the test day

 
Experiment 3

One-way ANOVAs yielded no significant differences in plasma insulin, glucose, or ghrelin at the time of death between NPY- and saline-trained groups (P > 0.05 in all cases, Table 5). There was also no difference in hypothalamic NPY mRNA between the NPY- and saline-trained groups (P > 0.05) (Table 5).


View this table:
[in this window]
[in a new window]
 
Table 5. Plasma values and NPY mRNA in rats that were retrained with 3 consecutive days of i3vt saline or NPY

 

    DISCUSSION
 TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
These experiments sought to assess the ability of animals trained to anticipate i3vt NPY to cope with unanticipated food, to test the hypothesis that NPY, rather than functioning to increase food intake per se, mediates food-anticipatory responses that help to cope with a large caloric load. To accomplish this, we first determined the duration of central NPY's effects on food intake when food is not available and its return delayed. Previous studies demonstrated that NPY increases food intake even after a 2-h delay in access (22). Therefore, we needed to ensure that the daily NPY injections would have no effect on food intake during the 4-h access period. In experiment 2, we therefore administered NPY (or saline) 18 h before food access. Consistent with the findings of experiment 1, rats receiving NPY ate the same amount of food and weighed the same as rats receiving saline over the seven daily training sessions in experiment 2.

In experiment 2, the key group of animals was trained to anticipate receiving i3vt NPY at precisely 1600 h. When they subsequently received a saline injection on day 8 at 1600 (NPY/Sal group on the test day), they behaved as if they had actually received NPY on that day, consuming as much food as the NPY/NPY animals. Importantly, both of these groups (NPY/Sal and NPY/NPY) ate the same amount of food on day 8 as rats that received NPY for the first time (Sal/NPY), and all three groups ate more food than the control rats (Sal/Sal). This effect persisted throughout 4 h but was gone by 20 h. These data have several implications. First, they suggest that repeated administration of NPY at the same time each day may initiate a sequence of endogenous events that normally allows an animal to anticipate and eat a large quantity of food. The results further imply that, whether the sequence of large meal-enabling events is elicited by exogenous NPY itself (i.e., Sal/NPY or NPY/NPY group) or by a stimulus that predicts NPY administration (i.e., injection procedure and time of day, NPY/Sal group), the effect is the same in that the rats eat more food than they otherwise would at that time. Finally, the results imply that the conditioned, NPY-anticipatory response (NPY/Sal group) is not enhanced by injection of exogenous NPY (NPY/NPY group); however, this assertion this requires further testing because only one dose of NPY was used in the present set of experiments.

Experiment 3 was an initial attempt to determine the mechanisms by which NPY may mediate meal-preparatory responses. It is well known that plasma insulin and ghrelin both rise in a predictable manner before an anticipated meal (9, 31). It is conceivable, therefore, that if the primary function of NPY is to mediate meal-anticipatory responses, training animals to anticipate NPY would condition them to make comparable anticipatory responses. The data, however, did not reveal any changes in these hormones. It should be emphasized, however, that only one time point was assessed and that, importantly, no injection was given on the day blood was collected. An injection per se has been found to be a critical part of the conditioned stimulus in drug-conditioning experiments when time of day is not precise and behavior is assessed (16), whereas time of day has been sufficient in other experiments, especially those assessing plasma levels of hormones (40). However, experiment 2 included both time of day and injections, whereas experiment 3 relied solely on the time of day cue. It is also possible that changes in these parameters took place at points earlier in the sequence leading up to the expectation of the NPY injection since cephalic insulin and ghrelin changes occurred before an anticipated meal (9, 31). Alternatively, it is possible that these hormones were not influenced at any time by the NPY conditioning. Plasma values of insulin, glucose, and ghrelin were all consistent with postprandial values, as they were measured at injection time, which was only 2 h after the 4-h meal-feeding period. Other important meal-anticipatory factors such as plasma corticosterone, body temperature, and locomotor activity need to be assessed with NPY conditioning in future studies.

Regardless of the mechanisms by which the daily NPY injections lead to an increase in feeding in the NPY/Sal group, it is important that the feeding effect and the hormonal responses were dissociated. Despite no differences in plasma ghrelin, insulin, or glucose, there was a large effect on behavior, suggesting that simultaneous changes in these hormones may not be necessary to initiate an increase in food intake. Although it is tempting to speculate that NPY may be able to override these hormonal signals in preparing an animal to ingest a large caloric load, the different procedures undertaken for experiments 2 and 3 make it difficult to draw such a conclusion.

Traditionally, it has been accepted that NPY functions to stimulate food intake. However, there is compelling evidence that, as an orexigenic peptide, NPY is important as a meal-anticipatory hormone that prepares animals for meal consumption. Consistent with this, when rats are on a strict meal-feeding schedule, they develop a reliable rise in extracellular NPY in the paraventricular nucleus 2 h before the scheduled meal (42). An analogous rise in arcuate nucleus NPY mRNA is also observed before dark onset, the time of the largest meal, in freely feeding rats (1). Further supporting this concept, mice that do not synthesize NPY (i.e., NPY–/– mice) have normal daily 24-h food intake and normal body weight (13), indicating that NPY is not necessary for animals to elicit meals. However, NPY–/– mice cannot anticipate meals properly, eating relatively small meals after being fasted (28). In addition, NPY–/– mice have an increased latency to eat after fasting, further implicating NPY in meal anticipation (28). The present data are consistent with these other data in that they support the hypothesis that NPY is involved in meal anticipation and does not function simply to stimulate food intake.


    GRANTS
 TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
This work was supported by National Institute of Diabetes and Digestive and Kidney Diseases Grants DK-63779 (D. L. Drazen), DK-17844 (S. C. Woods), and DK-54080 (R. J. Seeley). The Obesity Research Center at the University of Cincinnati is supported in part by Procter & Gamble.


    ACKNOWLEDGMENTS
 
The authors thank Kathi Smith for assistance and are grateful to Kay Ellis for running the plasma assays.


    FOOTNOTES
 

Address for reprint requests and other correspondence: S. C. Woods, Genome Research Institute, Univ. of Cincinnati, 2170 E. Galbraith Rd., Bldg. E, Rm. 313, Cincinnati, OH 45237 (E-mail: steve.woods{at}psychiatry.uc.edu)

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.


    REFERENCES
 TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 

  1. Akabayashi A, Levin N, Paez X, Alexander JT, and Leibowitz SF. Hypothalamic neuropeptide Y and its gene expression: relation to light/dark cycle and circulating corticosterone. Mol Cell Neurosci 5: 210–218, 1994.
  2. Ammar AA, Sederholm F, Saito TR, Scheurink AJ, Johnson AE, and Sodersten P. NPY-leptin: opposing effects on appetitive and consummatory ingestive behavior and sexual behavior. Am J Physiol Regul Integr Comp Physiol 278: R1627–R1633, 2000.
  3. Berthoud HR, Bereiter DA, Trimble ER, Siegel EG, and Jeanrenaud B. Cephalic phase, reflex insulin secretion. Neuroanatomical and physiological characterization. Diabetologia Suppl 20: 393–401, 1981.
  4. Brief DJ, Sipols AJ, and Woods SC. Intraventricular neuropeptide Y injections stimulate food intake in lean, but not obese Zucker rats. Physiol Behav 51: 1105–1110, 1992.
  5. Brunzell JD and Schrott HG. The interaction of familial and secondary causes of hypertriglyceridemia: role in pancreatitis. Trans Assoc Am Physicians 86: 245–254, 1973.
  6. Chavez M, Seeley RJ, and Woods SC. A comparison between effects of intraventricular insulin and intraperitoneal lithium chloride on three measures sensitive to emetic agents. Behav Neurosci 109: 547–550, 1995.
  7. Clark JT, Kalra PS, Crowley WR, and Kalra SP. Neuropeptide Y and human pancreatic polypeptide stimulate feeding behavior in rats. Endocrinology 115: 427–429, 1984.
  8. Craig W. Appetites and aversions as constituents of instincts. Biol Bull 34: 91–107, 1918.
  9. Cummings DE, Purnell JQ, Frayo RS, Schmidova K, Wisse BE, and Weigle DS. A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes 50: 1714–1719, 2001.
  10. De Boer SF and van der Gugten J. Daily variations in plasma noradrenaline, adrenaline, and corticosterone concentrations in rats. Physiol Behav 40: 323–328, 1987.
  11. De Vries J, Strubbe JH, Wildering WC, Gorter JA, and Prins AJ. Patterns of body temperature during feeding in rats under varying ambient temperatures. Physiol Behav 53: 229–235, 1993.
  12. Ensinck JW, Laschansky EC, Vogel RE, and D'Alessio DA. Effect of somatostatin-28 on dynamics of insulin secretion in perfused rat pancreas. Diabetes 40: 1163–1169, 1991.
  13. Erickson JC, Hollopeter G, and Palmiter RD. Attenuation of the obesity syndrome of ob/ob mice by the loss of neuropeptide Y. Science 274: 1704–1707, 1996.
  14. Even PC and Nicolaidis S. Adaptive changes in energy expenditure during mild and severe feed restriction in the rat. Br J Nutr 70: 421–431, 1993.
  15. Haas DA and George SR. Neuropeptide Y administration acutely increases hypothalamic corticotropin-releasing factor immunoreactivity: lack of effect in other rat brain regions. Life Sci 41: 2725–2731, 1987.
  16. Hutton RA, Woods SC, and Makous WL. Conditioned hypoglycemia: pseudoconditioning controls. J Comp Physiol Psychol 71: 198–201, 1970.
  17. Inoue S, Bray GA, and Mullen YS. Transplantation of pancreatic {beta}-cells prevents development of hypothalamic obesity in rats. Am J Physiol Endocrinol Metab Gastrointest Physiol 235: E266–E271, 1978.
  18. Keys A, Menotti A, Karvonen MJ, Aravanis C, Blackburn H, Buzina R, Djordjevic BS, Dontas AS, Fidanza F, Keys MH, and et al. The diet and 15-year death rate in the seven countries study. Am J Epidemiol 124: 903–915, 1986.
  19. Kissilef HR. Free feeding in normal and "recovered lateral" rats monitored by a pellet-detecting eatometer. Physiol Behav 5: 163–173, 1970.
  20. Klaff LJ and Palmer JP. Risks for glucose intolerance. Cardiol Clin 4: 67–73, 1986.
  21. Landsberg L, Saville ME, and Young JB. Sympathoadrenal system and regulation of thermogenesis. Am J Physiol Endocrinol Metab 247: E181–E189, 1984.
  22. Morley JE, Levine AS, Gosnell BA, Kneip J, and Grace M. Effect of neuropeptide Y on ingestive behaviors in the rat. Am J Physiol Regul Integr Comp Physiol 252: R599–R609, 1987.
  23. Powley TL and Berthoud HR. Diet and cephalic phase insulin responses. Am J Clin Nutr 42: 991–1002, 1985.
  24. Richter CP. Experimentally produced reactions to food poisoning in wild and domesticated rats. Ann NY Acad Sci 56: 225–239, 1952.
  25. Rowe JW, Young JB, Minaker KL, Stevens AL, Pallotta J, and Landsberg L. Effect of insulin and glucose infusions on sympathetic nervous system activity in normal man. Diabetes 30: 219–225, 1981.
  26. Sainsbury A, Rohner-Jeanrenaud F, Cusin I, Zakrzewska KE, Halban PA, Gaillard RC, and Jeanrenaud B. Chronic central neuropeptide Y infusion in normal rats: status of the hypothalamo-pituitary-adrenal axis, and vagal mediation of hyperinsulinaemia. Diabetologia 40: 1269–1277, 1997.
  27. Seeley RJ, Payne CJ, and Woods SC. Neuropeptide Y fails to increase intraoral intake in rats. Am J Physiol Regul Integr Comp Physiol 268: R423–R427, 1995.
  28. Sindelar DK, Marsh DJ, Mystkowski P, Palmiter RD, and Schwartz MW. Attenuation of Diabetic Hyperphagia in Neuropeptide Y Deficient Mice. Abstract: Annual Meeting of the American Diabetes Association, 1999, p. A26.
  29. Smialowska M, Gastol-Lewinska L, and Tokarski K. The role of alpha-1 adrenergic receptors in the stimulating effect of neuropeptide Y (NPY) on rat behavioural activity. Neuropeptides 26: 225–232., 1994.
  30. Stanley BG and Leibowitz SF. Neuropeptide Y: stimulation of feeding and drinking by injection into the paraventricular nucleus. Life Sci 35: 2635–2642, 1984.
  31. Steffens AB. Influence of the oral cavity on insulin release in the rat. Am J Physiol 230: 1411–1415, 1976.
  32. Strubbe JH, Keyser J, Dijkstra T, and Prins AJ. Interaction between circadian and caloric control of feeding behavior in the rat. Physiol Behav 36: 489–493, 1986.
  33. Strubbe JH and Woods SC. The timing of meals. Psychol Rev 111: 128–141, 2004.
  34. Suda T, Tozawa F, Iwai I, Sato Y, Sumitomo T, Nakano Y, Yamada M, and Demura H. Neuropeptide Y increases the corticotropin-releasing factor messenger ribonucleic acid level in the rat hypothalamus. Brain Res Mol Brain Res 18: 311–315, 1993.
  35. Teff K. Nutritional implications of the cephalic-phase reflexes: endocrine responses. Appetite 34: 206–213, 2000.
  36. Woods SC. The eating paradox: how we tolerate food. Psychol Rev 98: 488–505, 1991.
  37. Woods SC, Hutton RA, and Makous W. Conditioned insulin secretion in the albino rat. Proc Soc Exp Biol Med 133: 964–968, 1970.
  38. Woods SC, Makous W, and Hutton RA. Temporal parameters of conditioned hypoglycemia. J Comp Physiol Psychol 69: 301–307, 1969.
  39. Woods SC and Strubbe JH. The psychobiology of meals. Psychonomic Bull Rev 1: 141–155, 1994.
  40. Woods SC, Vasselli JR, Kaestner E, Szakmary GA, Milburn P, and Vitiello MV. Conditioned insulin secretion and meal feeding in rats. J Comp Physiol Psychol 91: 128–133, 1977.
  41. Xu B, Kalra PS, Farmerie WG, and Kalra SP. Daily changes in hypothalamic gene expression of neuropeptide Y, galanin, proopiomelanocortin, and adipocyte leptin gene expression and secretion: effects of food restriction. Endocrinology 140: 2868–2875, 1999.
  42. Yoshihara T, Honma S, and Honma K. Effects of restricted daily feeding on neuropeptide Y release in the rat paraventricular nucleus. Am J Physiol Endocrinol Metab 270: E589–E595, 1996.




This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
288/6/R1606    most recent
00817.2004v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via ISI Web of Science (4)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Drazen, D. L.
Right arrow Articles by Woods, S. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Drazen, D. L.
Right arrow Articles by Woods, S. C.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2005 by the American Physiological Society.